Joyvié Health, a UK-based healthtech company, has raised €897,000 (approximately $1.04 million) in pre-seed funding to advance its continence underwear technology. The round was supported by HERmesa Angels, SyndicateRoom, and Lavender Ventures.
The company is developing specialized continence underwear designed to reduce stool-to-skin contact while simultaneously lowering the physical and emotional burden on caregivers. This dual focus addresses a significant gap in the continence care market, where existing solutions often fail to adequately meet the needs of both users and those providing care support.
Strategic Use of Capital
Joyvié Health plans to deploy the newly raised capital across several critical areas. The funding will support a direct-to-consumer product launch, enabling the company to bring its continence underwear directly to the market. Additionally, the investment will finance clinical pilots to validate the product’s effectiveness and safety, bolstering its credibility within the healthcare sector.
The company also intends to establish strategic partnerships that could accelerate market penetration and distribution, while using a portion of the funds to bring on key team members necessary for scaling operations.
Addressing Market Gaps
Continence care remains an underserved segment within the broader healthtech landscape. Current solutions often prioritize absorbency at the expense of comfort, dignity, and practical utility for caregivers managing multiple patients or family members. Joyvié Health’s approach of explicitly designing for both user comfort and caregiver efficiency represents a more holistic perspective on continence management.
The company’s focus on reducing stool-to-skin contact addresses both hygiene and health outcomes, potential areas where innovation could yield meaningful improvements over existing products currently available in the market.
Growing Healthtech Investment Trend
This funding round reflects continued investor interest in specialized healthtech solutions addressing specific health conditions and care scenarios. The involvement of angel networks like HERmesa Angels alongside equity crowdfunding platforms and venture firms demonstrates diverse confidence in the company’s proposition.
Europe’s startup ecosystem continues to develop specialized healthcare solutions targeting underserved patient populations and care gaps. Companies like Joyvié Health exemplify a broader trend toward personalized, user-centered healthtech innovations that go beyond traditional pharmaceutical or general medical device approaches. As regulatory frameworks across EU countries evolve to accommodate novel health solutions, and as healthcare systems increasingly embrace digital and product-based interventions, startups addressing specific care challenges are finding receptive markets and engaged investor communities.